The triglyceride glucose index and cardiovascular disease outcomes.
The triglyceride glucose index and cardiovascular disease outcomes.
复制标题
DOI:
10.1016/s2666-7568(22)00269-0
复制
发表时间:
2023-01
影响因子:
13.1
通讯作者:
Sussman, Jeremy B
中科院分区:
文献类型:
--
作者:
Flood, David;Brant, Luisa Campos Caldeira;Sussman, Jeremy B
Jaramillo and colleagues1 present results from the Prospective Urban Rural Epidemiology (PURE) study on the association between insulin resistance and cardiovascular disease outcomes. This study1 uses PURE data to introduce a novel cardiometabolic risk factor, the triglyceride glucose (TyG) index. The TyG index is a surrogate marker for insulin resistance, often considered the key pathophysiological abnormality in diabetes and prediabetes. It is calculated as the natural log of fasting triglycerides multiplied by fasting plasma glucose and therefore is practical to measure in primary care settings with laboratory capacity. This PURE analysis included 141 243 individuals aged 35–70 years who were followed up for a median of 13· 2 years (IQR 11· 9–14· 6) in 22 countries (5 lowincome countries [LICs], 13 middle-income countries [MICs], and 4 high-income countries [HICs]). The composite primary outcome was major cardiovascular disease events (non-fatal myocardial infarction or stroke) or death due to cardiovascular diseases. In the adjusted models, individuals in the highest TyG tertile had a greater incidence of the composite outcome compared with those in the lowest TyG tertile (HR 1· 21; 95% CI 1· 13–1· 30). Moreover, there was heterogeneity in the size of this association by country income group; a larger association was seen in LICs and MICs, while no association was observed in HICs. These findings are promising, but more knowledge is required for the role the TyG index in causal inference, describing inequity, predicting clinical risk, and implementing the marker in clinical practice.From a causal perspective, one challenge is disentangling the biological role of insulin resistance versus the known risk factors of elevated glucose and elevated triglycerides on cardiovascular disease risk. 2, 3 In other words, how much of the explanatory power of the TyG index is not mediated via a pathway of insulin resistance? In a sensitivity analysis, the authors reported that the TyG index had a greater hazard ratio for incident cardiovascular diseases than tertiles of glucose or triglycerides in separate models. The authors hypothesise that the higher hazard ratios for